Informax Forecasts Strong Future Revenues; Shares Slip Following News | GenomeWeb

NEW YORK, Jan 4 - Informax said Thursday increased sales of Genomax and Vector NTI software would help to drive up fourth quarter revenues to $5.3 million while new bookings of $6.7 million in the quarter would generate strong revenues in the future.

In a conference call to discuss the company’s earnings outlook, CFO Joseph Lehnan said he expects “a very aggressive” 2001, predicting revenues of $32 million next year, almost double a projected $16.6 million for 2000. Informax said it was on track to achieve profitability by 2002.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.